Clinical trial
Phase II Trial of Taxotere and Oxaliplatin Combination Chemotherapy in Squamous Cell Carcinoma of the Head and Neck
NCT00184028 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial of Taxotere and Oxaliplatin Combination Chemotherapy in Squamous Cell Carcinoma of the Head and Neck
- Lead sponsor
- University of Southern California
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 30, 2004
- Completion date
- July 31, 2010
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
carcinoma of the head and neck